KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,552 | – | 399 | +731.2% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 48 | -79.6% | 0.00% | – |
Q2 2022 | $1,000 | -83.3% | 235 | -59.1% | 0.00% | -100.0% |
Q2 2021 | $6,000 | -88.0% | 575 | -82.0% | 0.00% | -91.7% |
Q4 2020 | $50,000 | +4900.0% | 3,200 | +5145.9% | 0.01% | – |
Q3 2020 | $1,000 | -88.9% | 61 | -87.8% | 0.00% | -100.0% |
Q2 2020 | $9,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |